Predictors Associated With Stroke or Systemic Embolism in Atrial Fibrillation Patients With a CHA2DS2-VA Score of 0 or 1

Recruiting

Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria (Experimental Group):
- Patients who experienced the stroke or systemic embolism between 2013 and 2016
- Patients who had AF before the occurrence of the stroke or systemic embolism
- Patients whose CHA2DS2-VASc score of 0 or 1 in men or CHA2DS2-VASc score of 1 or 2 in female at the time of the the stroke or systemic embolism
- Willing and able to provide informed consent
- Age greater than or equal to 18 years
Inclusion Criteria (Control Group):
- Patients who did not experience the stroke or systemic embolism between 2013 and 2016
- Patients who had AF
- Patients whose CHA2DS2-VASc score of 0 or 1 in men or CHA2DS2-VASc score of 1 or 2 in female at the time of the the stroke or systemic embolism
- Willing and able to provide informed consent
- Age greater than or equal to 18 years
Exclusion Criteria (Both experiment and control groups)
- Patients who do not meet all of the above listed inclusion criteria
- Patients with more than mild mitral valve stenosis or prosthetic mitral valve